Business & Industry
Business & Industry
400 Global Regulatory Manufacturing Approvals for Samsung Biologics
Samsung Biologics announced on November 26, 2025, that it has gone on to achieve a whopping 400 regulatory manufacturing approvals all over the world due to its...
Business & Industry
AstraZeneca, Biopharma Giant, Announces $2bn Investment in Maryland
It should not be termed as an overstatement when we say that Maryland is fast becoming the home away from home when it comes to...
BioPharma
Adaptive Clinical Supply Planning for Multi-Arm and Platform Trials
The clinical research landscape has undergone a fundamental transformation in recent years, with traditional two-arm trial designs giving way to more sophisticated multi-arm and platform...
BioPharma
Australian Biopharma to Expand US Plasma-Derived Therapies
The Australian-based biopharma company, CSL, plans to invest almost $1.5 billion in the next five years so as to expand its presence in the U.S....
Business & Industry
Pfizer to Acquire Metsera in a $10bn Deal as Board Backs
The news of Pfizer to acquire Metsera in a $10bn deal has indeed caught the eye of many. Metsera happens to be a US-based biotechnology...
BioPharma
Sofinnova Partners Raises $750mn to Support Biotech Startups
European venture capital firm Sofinnova Partners said on November 17 that it raised 650 million euros, equivalent to $750 million, for a new fund that...
Business & Industry
J&J Buys Halda for $3bn to Own the Cell Death Platform
Johnson & Johnson will be paying $3.05 billion so as to acquire Halda Therapeutics, thereby getting a novel cell death platform while at the same time...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.